TCT

SAN DIEGO — Patients who underwent PCI with a newer-generation everolimus-eluting stent had a similar risk for target lesion revascularization compared with those who underwent the procedure with a first-generation sirolimus-eluting stent, according to data presented at TCT 2018.

SAN DIEGO — An interventional diagnostic procedure for patients with angina and without obstructive CAD was safe, feasible and led to a change in physician diagnosis in nearly half of patients, according to data from the CorMicA trial presented at TCT 2018.

SAN DIEGO — A trial of a renal denervation technology in patients with resistant hypertension was stopped for futility because it was not going to be able to meet its primary endpoint, but it showed promise for improving 6-month outcomes, according to a presentation at TCT 2018.

SAN DIEGO — Among patients who had PCI with a drug-eluting stent, 1 month of combination ticagrelor and aspirin therapy followed by ticagrelor alone conferred better bleeding outcomes at 2 years than 1-year clopidogrel plus aspirin followed by 1-year aspirin monotherapy in patients with ACS, according to new data from the GLOBAL LEADERS study presented at TCT 2018.

SAN DIEGO — A novel device to treat pulmonary hypertension won the Shark Tank Innovation Competition held at TCT 2018.

SAN DIEGO — Cardiology Today’s Intervention was on-site at TCT 2018 to report on the latest developments in interventional cardiology. Here are the most popular stories from the meeting. Our readers were interested in transcatheter mitral valve repair for functional mitral regurgitation, anticoagulation strategies in patients with stenting and atrial fibrillation, CABG vs. PCI in left main disease, transcatheter aortic valve replacement vs. surgery in high-risk patients and more.

SAN DIEGO —Interventional tricuspid edge-to-edge valve repair with a transcatheter device in patients with tricuspid regurgitation was safe and resulted in a high procedural success rate, according to data from the TriValve registry presented at TCT 2018.

SAN DIEGO — A new zotarolimus-eluting stent designed to improve radiographic visibility while reducing strut thickness was noninferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent, according to the BIONYX trial.

SAN DIEGO — Randomized controlled trials and systematic data are necessary to impact how to treat patients with critical limb ischemia, in addition to learning more about how to reduce costs and positively change practice patterns, according to a presentation at TCT 2018.

SAN DIEGO — Among older patients with severe aortic stenosis at low or intermediate risk, surgical aortic valve replacement was associated with lower rates of all-cause mortality and rehospitalization for HF compared with transfemoral transcatheter aortic valve replacement using first-generation devices, according to 5-year findings from the OBSERVANT trial presented at TCT 2018.